Literature DB >> 12185453

Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.

Dirk Isbrandt1, Patrick Friederich, Anna Solth, Wilhelm Haverkamp, Andreas Ebneth, Martin Borggrefe, Harald Funke, Kathrin Sauter, Günter Breithardt, Olaf Pongs, Eric Schulze-Bahr.   

Abstract

Long-QT syndrome (LQTS) may cause syncope and sudden death due to cardiac tachyarrhythmia. Chromosome 7-linked LQTS (LQT2) has been correlated with mutations in the human ether-a-go-go-related gene (HERG). HERG forms voltage-gated K channels that may be associated with Mink-related peptide 1 (MiRP1), an auxiliary beta-subunit. The channels mediate currents that resemble native I(Kr). Mutations in the KCNE2 gene encoding MiRP1 may also cause LQTS. In this study, the frequency of mutations in KCNE2 of 150 unrelated LQTS patients without known genotype and of 100 controls was analyzed using single-strand conformation polymorphism analysis and direct sequencing. We identified a novel missense mutation, V65 M, in the KCNE2 gene of a 17-year-old female with syncope and LQTS. Expression studies in Chinese hamster ovary cells revealed that mutant and wild-type MiRP1 co-localized with HERG subunits and formed functional channels. However, mutant HERG/MiRP1(V65M) channels mediated currents with an accelerated inactivation time course compared with wild-type channels. The accelerated inactivation time course of HERG/MiRP1(V65M) channels may decrease I(Kr) current density of myocardial cells, thereby impairing the ability of myocytes to repolarize in response to sudden membrane depolarizations such as extrasystoles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185453     DOI: 10.1007/s00109-002-0364-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  21 in total

Review 1.  HERG1 channelopathies.

Authors:  Michael C Sanguinetti
Journal:  Pflugers Arch       Date:  2009-11-22       Impact factor: 3.657

2.  Probing the interaction between KCNE2 and KCNQ1 in their transmembrane regions.

Authors:  Xian-Sheng Liu; Mei Zhang; Min Jiang; Dong-Mei Wu; Gea-Ny Tseng
Journal:  J Membr Biol       Date:  2007-08-04       Impact factor: 1.843

3.  Endogenous KCNE subunits govern Kv2.1 K+ channel activation kinetics in Xenopus oocyte studies.

Authors:  Earl Gordon; Torsten K Roepke; Geoffrey W Abbott
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

4.  KCNE4 domains required for inhibition of KCNQ1.

Authors:  Lauren J Manderfield; Melissa A Daniels; Carlos G Vanoye; Alfred L George
Journal:  J Physiol       Date:  2008-11-24       Impact factor: 5.182

5.  Regulation of the Kv2.1 potassium channel by MinK and MiRP1.

Authors:  Zoe A McCrossan; Torsten K Roepke; Anthony Lewis; Gianina Panaghie; Geoffrey W Abbott
Journal:  J Membr Biol       Date:  2009-02-14       Impact factor: 1.843

6.  KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels.

Authors:  Morten Grunnet; Hannne B Rasmussen; Anders Hay-Schmidt; Maiken Rosenstierne; Dan A Klaerke; Søren-Peter Olesen; Thomas Jespersen
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

Review 7.  Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Nat Rev Cardiol       Date:  2012-01-31       Impact factor: 32.419

Review 8.  The KCNE2 K⁺ channel regulatory subunit: Ubiquitous influence, complex pathobiology.

Authors:  Geoffrey W Abbott
Journal:  Gene       Date:  2015-06-27       Impact factor: 3.688

Review 9.  Working model for the structural basis for KCNE1 modulation of the KCNQ1 potassium channel.

Authors:  Wade D Van Horn; Carlos G Vanoye; Charles R Sanders
Journal:  Curr Opin Struct Biol       Date:  2011-02-04       Impact factor: 6.809

10.  Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f).

Authors:  Torsten K Roepke; Andrianos Kontogeorgis; Christopher Ovanez; Xianghua Xu; Jeffrey B Young; Kerry Purtell; Peter A Goldstein; David J Christini; Nicholas S Peters; Fadi G Akar; David E Gutstein; Daniel J Lerner; Geoffrey W Abbott
Journal:  FASEB J       Date:  2008-07-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.